Surmodics' growing returns on capital and ability to consistently reinvest at higher rates are encouraging, and with its stock having fallen 23% over the last five years, there may be a potential investment opportunity, provided these trends continue.
SurModics股票讨论区
$发现金融(DFS.US)$ $Genius Group(GNS.US)$ $克罗格(KR.US)$ $Lytus Technologies Holdings(LYT.US)$ $智富融资(MEGL.US)$ $奈飞(NFLX.US)$ $NeuroSense Therapeutics(NRSN.US)$ $Nuzee(NUZE.US)$ $Roblox(RBLX.US)$ $嘉信理财(SCHW.US)$ $SurModics(SRDX.US)$ $TC BioPharm(TCBP.US)$ $Tempo Automation(TMPO.US)$ $台积电(TSM.US)$
暂无评论